Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 1.8B | 1.9B | 1.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 337M | 252M | 293M | 295M |
Other operating expenses | 0 | 216M | 8M | 116M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 859M | 450M | 1.0B | 1.0B |
Tax provision | 214M | 84M | 267M | 255M |
Net income | 645M | 366M | 772M | 763M |
Basic EPS | 12.3 | — | 14.3 | — |
Diluted EPS | 12.3 | — | 14.3 | — |
Basic average shares | 53.3M | — | 52.9M | — |
Diluted average shares | 53.3M | — | 52.9M | — |
EBITDA | — | — | — | — |
Net income from continuing op. | 859M | 450M | 1.0B | 1.0B |
Minority interests | -3M | — | -5M | -1M |
Preferred stock dividends | 10M | — | 10M | 9M |